Philip Barie, MD, General Surgery, New York, NY, Hospital for Special Surgery

PhilipSBarieMDMBA FIDSA FCCM FACS

General Surgery New York, NY

Trauma Surgery & Surgical Critical Care

Professor of Surgery and Public Health Weill Cornell Medical College

Dr. Barie is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Barie's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusResidency, General Surgery, 1982 - 1984
  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusResidency, General Surgery, 1977 - 1979
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1977

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2020
  • NY State Medical License
    NY State Medical License 1978 - 2021
  • American Board of Surgery Surgery
  • American Board of Surgery Surgical Critical Care

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • New York Magazine: Top Doctors Castle Connolly, 2010, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Timing of Trauma Service Consultation: A Trauma Registry Analysis of Patient and Injury FactorsOctober 2018

Press Mentions

  • Ebola Control Measures Seem to Be Working in Congo, World Health Organization Says
    Ebola Control Measures Seem to Be Working in Congo, World Health Organization SaysNovember 13th, 2018
  • Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
    Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)October 29th, 2018
  • FDA Approves Eravacycline to Tackle Intra-Abdominal Infections
    FDA Approves Eravacycline to Tackle Intra-Abdominal InfectionsAugust 29th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations